A Unique Product Providing Real Parental Reassurance
NEW YORK, May 22 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced the commencement of field trials for its latest homecare wellness product using SPO's patented technology and creating a new application for the traditional home baby monitor market.
Each year, there are approximately 4.1 million births in the US alone, of which over half are first time births; the statistics are similar for Western Europe. First time parents are particularly apprehensive about their new experiences and responsibilities with newborns; SPO's new baby monitor is designed to specifically address these early concerns and provides maximum reassurance for the new parents.
Many of today's typical baby monitors require the interaction of the parent or caregiver, in contrast to SPO's reassurance monitor that is proactive with an alarm call in the event that parental action is required. The Company's proprietary and patented technology uses information gathered from the reflectance of light, in a non-invasive manner, to monitor certain vital signs of the baby. Based on this proprietary technology, the baby monitor accurately and reliably measures the heart movement and analyzes the signal using proprietary algorithms to inform the parent of a potential change in the wellness status of the baby; this allows the parent to be proactive in addressing the needs of the baby at any given time.
"SPO is pleased to be able to bring to every parent a product that could give them greater reassurance as to the wellbeing of their babies," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "The baby monitoring market has been waiting for a development of this kind of product for several years - the nature of our product delivers real parental reassurance using our proprietary recognized technology that has been well proven by SPO in the professional medical and homecare markets. Responses to this new product concept have been very encouraging as evidenced by our extensive market survey and focus groups carried-out across the US.". Braunold continued, "Our market data indicated that there are some 2.5 million baby monitors purchased per annum in the US alone; this represents a tremendous market potential for the product and for the Company in general."
The baby monitor consists of an ankle bracelet encasing a unique optical sensor which will be worn by the baby, an audio base unit and a parents receiving unit. The units are fully portable and also operate as a conventional voice system for standard audio monitoring of the baby. The system is wireless based on the use of safe RF technology for transmitting the data between the baby and the parent. In addition, the baby bracelet contains a rechargeable battery eliminating the need to change batteries on a frequent basis.
Visit http://www.spobaby.com to keep updated on the development of this new and exciting consumer product opportunity.
About SPO Medical:
SPO Medical (OTC: SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spomedical.com.
Forward Looking Statements:
This press release contains forward-looking statements that involve
substantial uncertainties and risks. These forward-looking statements are
based upon our current expectations, estimates and projections about our
business and our industry, and that reflect our beliefs and assumptions
based upon information available to us at the date of this release. We
caution readers that forward-looking statements are predictions based on
our current expectations about future events. These forward-looking
statements are not guarantees of future performance and are subject to
risks, uncertainties and assumptions that are difficult to predict. Our
actual results, performance or achievements could differ materially from
those expressed or implied by the forward-looking statements as a result of
a number of factors, including but not limited to, changes in economic
conditions generally and the medical devices market specifically, changes
in technology, legislative or regulatory changes that affect us, the
availability of working capital, the introduction of competing products,
market acceptance of our new products, changes in our operating strategy or
development plans and the risks and uncertainties discussed under the
heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for
the fiscal year ended December 31, 2007. We undertake no obligation to
revise or update any forward-looking statement for any reason.
SPO Medical Contact:
Michael Braunold, President & CEO
ACV Contact: Howard Gostfrand / David Sasso
|SOURCE SPO Medical Inc.|
Copyright©2008 PR Newswire.
All rights reserved